Personal tools

MCL coexpression mm9:338

From FANTOM5_SSTAR

Revision as of 16:11, 10 October 2012 by Autoedit (talk | contribs) (Created page with "{{MCL_coexpression_mm9|gostat_on_MCL_coexpression=GO:0032788;saturated monocarboxylic acid metabolic process;0.0124900708008226;171281!GO:0032789;unsaturated monocarboxylic ac...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search


Phase1 CAGE Peaks

 Short description
Mm9::chr10:127303468..127303473,+p6@BC089597
Mm9::chr12:85393097..85393107,+p2@Acot3
Mm9::chr13:23931446..23931456,+p4@Slc17a3
Mm9::chr13:23972751..23972753,+p@chr13:23972751..23972753
+
Mm9::chr14:49860853..49860856,-p@chr14:49860853..49860856
-
Mm9::chr15:27925075..27925093,-p@chr15:27925075..27925093
-
Mm9::chr18:35775051..35775061,-p@chr18:35775051..35775061
-
Mm9::chr19:12774597..12774607,+p@chr19:12774597..12774607
+
Mm9::chr19:40562058..40562081,-p@chr19:40562058..40562081
-
Mm9::chr2:162833196..162833199,+p@chr2:162833196..162833199
+
Mm9::chr2:163335366..163335380,-p@chr2:163335366..163335380
-
Mm9::chr2:167864910..167864915,-p@chr2:167864910..167864915
-
Mm9::chr3:121898002..121898005,-p@chr3:121898002..121898005
-
Mm9::chr4:128295560..128295571,-p@chr4:128295560..128295571
-
Mm9::chr4:137222270..137222274,-p@chr4:137222270..137222274
-
Mm9::chr5:89514525..89514545,+p@chr5:89514525..89514545
+
Mm9::chr5:89531075..89531084,+p@chr5:89531075..89531084
+
Mm9::chr5:89537758..89537769,+p@chr5:89537758..89537769
+
Mm9::chr7:126759226..126759230,-p@chr7:126759226..126759230
-
Mm9::chr7:31099193..31099204,-p@chr7:31099193..31099204
-
Mm9::chr8:62997035..62997039,+p@chr8:62997035..62997039
+
Mm9::chr8:63003002..63003009,+p@chr8:63003002..63003009
+
Mm9::chr9:71572350..71572363,-p@chr9:71572350..71572363
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0032788saturated monocarboxylic acid metabolic process0.0124900708008226
GO:0032789unsaturated monocarboxylic acid metabolic process0.0124900708008226
GO:0000038very-long-chain fatty acid metabolic process0.0249514138627973
GO:0016290palmitoyl-CoA hydrolase activity0.0249514138627973
GO:0006637acyl-CoA metabolic process0.0249514138627973
GO:0016291acyl-CoA thioesterase activity0.0249514138627973
GO:0001676long-chain fatty acid metabolic process0.0249514138627973
GO:0016289CoA hydrolase activity0.0249514138627973



Relative expression of the co-expression cluster over median <br>Analyst:



"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}